AB038. Pragmatic trial comparing continuing Seretide(®) MDI with changing to Flutiform(®) in asthma

BACKGROUND: Selecting the most appropriate asthma therapy for individual patients can be challenging owing to limited data on real-life effectiveness of inhaled corticosteroid (ICS)/long-acting beta2-agonist (LABA) combinations available. Various factors, such as ease of use of the device and speed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Dis
Autores principales: Kemppinen, Anu, Gardener, Elizabeth, Thomas, Vicky, Raju, Priyanka, Callan, Christina, McLoughlin, Andrew, Woodhead, Vanessa, Brady, Adam, Juniper, Elizabeth F., Barnes, Peter J., Usmani, Omar S., Price, David
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2016
Materias:
Poster Session
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4958772/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2016.s038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares